title: Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice.
abstract: In this study the ability of recombinant gp63 entrapped in liposomes to induce immune response and protection against L. major infection in susceptible BALB/c mice was studied. Liposomes containing rgp63 (Lip-rgp63) were prepared from egg lecithin and cholesterol using detergent solubilization method. Immunization of BALB/c mice with rgp63 alone conferred a partial protection while entrapment of rgp63 in liposomes significantly increased the rate of protection (P<0.05). The parasite burden of spleen in mice challenged with L. major was significantly (p<0.001) lower in group of mice immunized with rgp63 alone or Lip-rgp63, however, the least parasite burden was seen in Lip-rgp63 group. Both rgp63 alone and Lip-rgp63 elicited significant delayed-type hypersensitivity (DTH) response compared to controls (p<0.01), however, the DTH response of PBS-rgp63 was less than the Lip-rgp63. Titration of anti-Leishmania IgG isotypes (IgG2a/IgG1) showed a preferential Th1 type of immune response only in mice immunized with Lip-rgp63. The results indicate that liposomes might be used as a suitable immunoadjuvant for development of Leishmania vaccine.
authors.affiliation: School of Pharmacy, Biotechnology Research Center, Mashhad University of Medical Sciences, P.O. Box 91775-1365, Mashhad, Iran. mr_jaafari@yahoo.com
authors.forename: Mahmoud R
authors.initials: MR
authors.lastname: Jaafari
authors.forename: Attieh
authors.initials: A
authors.lastname: Ghafarian
authors.forename: Ahsan
authors.initials: A
authors.lastname: Farrokh-Gisour
authors.forename: Afshin
authors.initials: A
authors.lastname: Samiei
authors.forename: Masoumeh Tavassoti
authors.initials: MT
authors.lastname: Kheiri
authors.forename: Fereidoun
authors.initials: F
authors.lastname: Mahboudi
authors.forename: Farzaneh
authors.initials: F
authors.lastname: Barkhordari
authors.forename: Ali
authors.initials: A
authors.lastname: Khamesipour
authors.forename: W Robert
authors.initials: WR
authors.lastname: McMaster
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D005260:Female; D018320:Leishmania major / Q000254:growth & development / Q000276:immunology* / Q000472:pathogenicity; D016773:Leishmaniasis, Cutaneous / Q000276:immunology / Q000517:prevention & control*; D008081:Liposomes / Q000008:administration & dosage*; D008666:Metalloendopeptidases / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016052:Protozoan Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D000913:Antibodies, Protozoan; D008081:Liposomes; D016052:Protozoan Vaccines; D011994:Recombinant Proteins; D008666:Metalloendopeptidases; C055146:glycoprotein gp63, Leishmania